Multicenter experience with digital single-operator cholangioscopy in pregnant patients
- PMID: 33532547
- PMCID: PMC7834694
- DOI: 10.1055/a-1320-0084
Multicenter experience with digital single-operator cholangioscopy in pregnant patients
Abstract
Background and study aims The use of fluoroscopy during pregnancy should be minimized given that a clear-cut safe radiation dose in pregnancy is unknown. The role of digital single-operator cholangioscopy (D-SOC) as an alternative to standard enodoscopic retrograde cholangiopancreatography (ERCP) in pregnant patients has not been comprehensively studied. This study assessed 1 Technical success defined as performance of ERCP with D-SOC without the use of fluoroscopy in pregnant patients; 2 safety of D-SOC in pregnancy; and 3 maternal and neonatal outcomes after D-SOC during/after pregnancy. Patients and methods This was an international, multicenter, retrospective study at 6 tertiary centers. Pregnant patients who underwent D-SOC for the treatment of bile duct stones and/or strictures were included. Results A total of 10 patients underwent D-SOC. Indications for ERCP were choledocholithiasis, strictures, previous stent removal, and choledocholithiasis/stent removal. Bile duct cannulation without fluoroscopy was achieved in 10 of 10 patients (100 %). Moreover, 50 % of patients (5/10) completed a fluoroless ERCP with D-SOC. Mean fluoroscopy dose and fluoroscopy time were 3.4 ± 7.2 mGy and 0.5 ± 0.8 min, respectively. One case of mild bleeding and one case of moderate post-ERCP pancreatitis occurred. The mean gestational age at delivery was 36.2 ± 2.6 weeks. Median birth weight was 2.5 kg [IQR: 2.2-2.8]. No birth defects were noted. Conclusion ERCP guided by D-SOC appears to be a feasible and effective alternative to standard ERCP in pregnant patients. It enables avoidance of radiation in half of cases.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Competing interests Dr. Jamidar is a speaker for Boston Scientific. Dr. Robles-Medranda is a key opinion leader and consultant for Pentax Medical, Boston Scientific, G-Tech medical supply, and MD Consulting group. Dr. Khashab is a consultant for Boston Scientific, Medtronic, and Olympus.
Figures

References
-
- Valdivieso V, Covarrubias C, Siegel F et al.Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology. 1993;17:1–4. - PubMed
-
- Ibiebele I, Schnitzler M, Nippita T et al.Outcomes of gallstone disease during pregnancy: a population-based data linkage study. Paediatr Perinat Epidemiol. 2017;31:522–530. - PubMed
-
- Bowie J M, Calvo R Y, Bansal V et al.Association of complicated gallstone disease in pregnancy and adverse birth outcomes. Am J Surg. 2020;220:745–750. - PubMed
-
- Date R S, Kaushal M, Ramesh A. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg. 2008;196:599–608. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources